Search Results

Building a Pulmonary Embolism Lysis Practice

Our strategy for assembling a team of specialists to provide efficient and effective acute PE care.

By Akhilesh K. Sista, MD; Oren A. Friedman, MD; James M. Horowitz, MD; and Arash Salemi, MD

Venous Pathways

By Barry Katzen, MD

Establishing a Pulmonary Embolism Response Team

Experts share their advice on the best approach to forming a “PERT” and discuss the benefits that they can offer.

With Ido Weinberg, MD; Michael R. Jaff, DO; James Horowitz, MD; Oren Friedman, MD; Ronald Winokur, MD; Akhilesh Sista, MD; and Keith M. Sterling, MD

PE Response Teams: Evolution Within the Revolution

Early adopters of the PERT concept share practical insights on forming an effective team.

Moderator: Rachel P. Rosovsky, MD, MPH;
Panelists: George Davis, PharmD; James Horowitz, MD; Brent Keeling, MD; Vicki McNally, MSN, RN, NP; John Moriarty, MD, FSIR; Soophia Naydenov, MD, FCCP; Fionnuala Ní Áinle, MD, PhD; and Charles B. Ross, MD, FACS, DFSVS

The Next Generation of Aortic Endografts

Developing trends and new technologies.

By David H. Deaton, MD

Renal Vein Access

Percutaneous transrenal placement of a tunneled dialysis catheter is feasible in some patients who have exhausted their traditional venous access sites.

By Seng H. Ong, MD, and Ramon G. Halum, MD

Venous Sinus Stenting for Idiopathic Intracranial Hypertension

A review of risk factors, pathophysiology, medical treatment options, the role of venous sinus stenting, and future directions, including ongoing clinical trials.

By Saman Sizdahkhani, MD, MS, and Reid Gooch, MD

Endovascular Management of Common and Internal Iliac Artery Aneurysms

How iliac branch grafting may become a first-line treatment option.

By Erin H. Murphy, MD, and Edward Y. Woo, MD

Middle Meningeal Artery Embolization in the Treatment of Chronic Headaches

Exploring middle meningeal artery embolization as a promising experimental therapy for chronic headaches, emphasizing the need for further clinical trials to validate efficacy, optimize patient selection and the technical approach, and ensure safety.

By Christopher H. Sollenberger, MS; Kyle Scott, MD; Aaron Anandarajah; Redi Rahmani, MD; Eric A. Kaiser, MD; Visish M. Srinivasan, MD; Jan Karl Burkhardt, MD, MBA; Seniha Ozudogru, MD; Bryan Pukenas, MD; and Joshua Catapano, MD

Tips, Tricks, and Pitfalls for Thrombosed AVFs

Arteriovenous fistula thrombosis can be managed with careful consideration of treatment options and patient-specific factors.

By Troy Sanders, MS; Mark L. Lessne, MD, FSIR; Brian Holly, MD; and Jessica K. Stewart, MD

The Unanswered Questions of Venous Stenting

Michael R. Jaff, DO, discusses the differences between the arterial and venous stent landscapes and what the future might hold.

Resistant Hypertension: Clinical Considerations and the Potential for Renal Denervation

The current landscape of major clinical trials and treatment.

By Vikas Kapil, MD, MRCP, PhD, and Melvin D. Lobo, MD, FRCP, PhD

CAS Technology Advancement

The opportunity to improve outcomes with new device approaches.

By Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD

An Interview With Katharine McGinigle, MD, MPH

Dr. McGinigle discusses her current and future research efforts in limb preservation, precision medicine and machine learning for CLTI, Enhanced Recovery After Surgery programs, disparity reduction, and more.

Asymptomatic CAS Trial Designs

John H. Rundback, MD, of the TACIT trial, and Sumaira Macdonald, MD, of ACST-2 discuss the necessary elements to evaluate the current state of care for treating asymptomatic carotid stenosis.

By John H. Rundback, MD and Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD

Immunotherapy and Checkpoint Inhibitors: A Primer for the Interventional Radiologist

The basics of immunology, immunotherapy, and checkpoint inhibitors.

By Joseph P. Erinjeri, MD, PhD, and Daniel T. Sze, MD, PhD